Repligen (RGEN) Cash from Financing Activities (2010 - 2026)
Repligen's (RGEN) quarterly Cash from Financing Activities came in at -$5.5 million in Q1 2026, down 10.2% year-on-year from -$6.2 million in Q1 2025, and down 2942.56% on a QoQ basis from $195000.0 in Q4 2025.
Repligen (RGEN) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Repligen (RGEN) has 17 years of Cash from Financing Activities data on file, last reported at -$5.5 million in Q1 2026.
- On a quarterly basis, Cash from Financing Activities fell 10.2% year-over-year to -$5.5 million in Q1 2026; TTM through Mar 2026 was -$15.7 million, a 80.09% increase from a year earlier, with the FY2025 full-year figure at -$15.2 million, up 81.66% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$5.5 million, down from $195000.0 in the prior quarter.
- Over the last five years, Cash from Financing Activities for RGEN reached as high as $268.1 million in Q4 2023 and fell as low as -$69.6 million in Q3 2024.
- Historically, Cash from Financing Activities has averaged $7.8 million across 5 years, with a median of -$5.0 million in 2025.
- Across the five-year window, Cash from Financing Activities soared 97956.57% in 2023 and plunged 8846.53% in 2024, its largest moves.
- Year by year, Cash from Financing Activities stood at -$274000.0 in 2022, then surged by 97956.57% to $268.1 million in 2023, then plunged by 99.46% to $1.4 million in 2024, then slumped by 86.54% to $195000.0 in 2025, then tumbled by 2942.56% to -$5.5 million in 2026.
- Per Business Quant data, the three most recent Cash from Financing Activities figures were -$5.5 million in Q1 2026, $195000.0 in Q4 2025, and -$239000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -133.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -414.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -13.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | -255.24 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -50.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -48.13 Mn |
| 10 | Repligen | 7.75 Bn | 6.77 Bn | 108.28 Mn | -5.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.54 Mn |
| Mar 31, 2026 | -5.54 Mn |
| Dec 31, 2025 | 195,000.00 |
| Dec 31, 2025 | 195,000.00 |
| Sep 30, 2025 | -239,000.00 |
| Sep 30, 2025 | -239,000.00 |
| Jun 30, 2025 | -10.13 Mn |
| Jun 30, 2025 | -10.13 Mn |
| Mar 31, 2025 | -5.03 Mn |
| Mar 31, 2025 | -5.03 Mn |
| Dec 31, 2024 | 1.45 Mn |
| Dec 31, 2024 | 1.45 Mn |
| Sep 30, 2024 | -69.60 Mn |
| Sep 30, 2024 | -69.60 Mn |
| Jun 30, 2024 | -5.77 Mn |
| Jun 30, 2024 | -5.77 Mn |
| Mar 31, 2024 | -8.97 Mn |
| Mar 31, 2024 | -8.97 Mn |
| Dec 31, 2023 | 268.13 Mn |
| Dec 31, 2023 | 268.13 Mn |